Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Cerilliant
QuintilesIMS
Boehringer Ingelheim
Chinese Patent Office
Colorcon
Harvard Business School
Farmers Insurance
Accenture
Chubb

Generated: October 18, 2017

DrugPatentWatch Database Preview

Diphenhydramine hydrochloride; pseudoephedrine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for diphenhydramine hydrochloride; pseudoephedrine hydrochloride and what is the scope of diphenhydramine hydrochloride; pseudoephedrine hydrochloride patent protection?

Diphenhydramine hydrochloride; pseudoephedrine hydrochloride
is the generic ingredient in one branded drug marketed by Parke Davis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are twenty-three drug master file entries for diphenhydramine hydrochloride; pseudoephedrine hydrochloride.

Summary for Generic Name: diphenhydramine hydrochloride; pseudoephedrine hydrochloride

US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: see list23
Clinical Trials: see list2,477
Drug Prices:see low prices
DailyMed Link:diphenhydramine hydrochloride; pseudoephedrine hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis
BENYLIN
diphenhydramine hydrochloride; pseudoephedrine hydrochloride
SOLUTION;ORAL019014-001Jun 11, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Cantor Fitzgerald
Argus Health
US Army
Dow
Healthtrust
Moodys
UBS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot